Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.29 +0.09 (+3.89%)
As of: Oct 22, 2026 · 3:41 PM EDT

Rocket Pharmaceuticals (RCKT) Restructuring Costs (2025)

Updated

Rocket Pharmaceuticals (RCKT) posted Restructuring Costs of -$68,000 for Q4 2025.

Analysis

Rocket Pharmaceuticals (RCKT) Restructuring Costs (2025) Analysis & Trends

For FY2025, Rocket Pharmaceuticals' Restructuring Costs came in at $3.23 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.46 Bn 1,139.04 Bn 19.71 Bn
2 Johnson & Johnson 648.38 Bn 568.24 Bn 17.30 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn
4 Merck 367.73 Bn 322.11 Bn 12.21 Bn
5 Novartis Ag 303.35 Bn 267.34 Bn 11.24 Bn
6 Astrazeneca 268.20 Bn 241.88 Bn 12.86 Bn
7 Amgen 242.55 Bn 197.95 Bn 7.24 Bn
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn
10 Rocket Pharmaceuticals 257.22 Mn -26.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -68,000.00
Sep 30, 2025 -172,000.00
Jun 30, 2025 3.47 Mn
API Access

Rocket Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=RCKT&period=max&api_key=YOUR_API_KEY